Research is hope.
OCRA is funding cutting-edge science that is enabling discoveries, creating new treatments, and hastening desperately-needed breakthroughs.
We are here for you.
If you're newly diagnosed with ovarian cancer, in treatment, or in remission, you may have concerns surrounding COVID-19. We can help.
We are your voice on Capitol Hill.
We’re speaking up to educate policymakers, protect research funding, and expand access to quality treatment and care.
Honor a loved one.
Find out how you can honor your loved one by helping propel crucial ovarian cancer research.
News & Updates
Ovarian Cancer Resources & Support
OCRA is committed to offering patients, caregivers and friends the most up to date information about ovarian cancer, helpful resources, and options for support…
The Overview: May 2022
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month…
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: Patients with ovarian cancer of the high-grade serous carcinoma subtype and that no longer…
Urgent: Tell Your Senators to Increase Ovarian Cancer Research Funding
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for…
OCRA-Funded Study Pinpoints Partner Proteins That May Contribute to Ovarian Cancer Tumor Growth
The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania…
New Immunotherapy Combination May Help Combat Ovarian Cancer Tumors
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of…
Invested over $100M
in ovarian cancer research since 1998
future medical professionals since 2002
Advocated for $200M+
in government research and education funding in 2019
Fundraise for OCRA
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!